The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep
- 14 August 2001
- Vol. 19 (31) , 4417-4428
- https://doi.org/10.1016/s0264-410x(01)00196-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Site-directed immune responses in DNA vaccines encoding ligand–antigen fusionsVaccine, 2000
- The Emerging Role of CTLA-4 as an Immune AttenuatorImmunity, 1997
- CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast KineticsThe Journal of Experimental Medicine, 1997
- T Cell Activation Determined by T Cell Receptor Number and Tunable ThresholdsScience, 1996
- Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient miceImmunity, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970